拱东医疗：2025年净利同比预降67.37%-74.36%

Core Viewpoint - Gongdong Medical (605369) has announced a significant decline in its expected net profit for 2025, forecasting a drop of 67.37% to 74.36% year-on-year, with net profit projected between 44 million to 56 million yuan [4]. Financial Performance - The expected non-recurring net profit for 2025 is estimated to be between 54 million to 66 million yuan, reflecting a year-on-year decrease of 60.75% to 67.89% [4]. - As of January 23, the company's price-to-earnings ratio (TTM) is approximately 77.37 to 98.47 times, with a price-to-book ratio (LF) of about 2.52 times and a price-to-sales ratio (TTM) of around 3.85 times [4]. Reasons for Performance Decline - The decline in performance is attributed to several factors: 1. Goodwill Impairment: The company has recognized signs of impairment related to goodwill from its acquisition of Trademark Plastics Inc. (TPI), with an estimated impairment amount between 24 million to 30 million yuan due to TPI's operational challenges influenced by international trade policies and shipping cost fluctuations [13]. 2. Gross Margin Decrease: The gross margin has been affected by the slowdown in demand for certain products due to U.S. tariff policies and domestic medical procurement policies [14]. 3. Exchange Rate Fluctuations: Financial expenses related to exchange rate fluctuations have significantly reduced, contributing to the decline in net profit. Additionally, losses from investments in a controlled entity have impacted non-operating income by approximately 11 million yuan [15].